Since the start of the second COVID-19 wave in India, over 3,000 people are dying each day, which is 1 death every 5 minutes . These numbers are still believed to be grossly underreported and the extent of this horrific situation in India has been pouring out through SOS WhatsApp messages, videos of people pleading for oxygen, and family members driving throughout the night in search of a hospital bed .
However, with the arrival of vaccines, India has a real fighting chance against the virus. The Government of India needs to implement the world’s largest vaccination program. To date, only 9% of the population has been partially vaccinated and only 1.8% has been fully vaccinated . Recent amendments to the vaccine guidelines and inclusions for everyone above the age of 18 years have provided for greater opportunities for Governments and the private sector to collaborate on mass vaccination campaigns, ensuring that no one is left behind.
Together for India is a joint collaboration between the Global India Fund (GIF), a U.S.-based 501c3 organization, and the Collective Good Foundation (CGF) in India. With vaccinated communities, the spread of the virus can be curbed, and people are able to go back to work and care for their families. Vaccines are THE PUBLIC HEALTH SOLUTION.
To ensure that vaccines are equitably distributed among marginalized communities and those in need, GIF and CGF are working with local organizations in India to provide financial support directly towards COVID-19 vaccination acquisition and distribution. GIF/CGF will support the purchasing of COVID-19 vaccines, increase vaccine awareness, decrease vaccine hesitancy, strengthen and build capacity to administer vaccines to disadvantaged groups. GIF and CGF have a long-standing partnership and are working with credible existing partners to set up vaccination centers in local communities in India.
We believe trusted partners in the community will combat vaccine hesitancy and ensure that those most in need will be vaccinated. Since the start of the COVID-19 pandemic, we have been actively working on-the-ground with implementation partners (NGOs, corporations, and foundations) and local governments as part of the REVIVE initiative. REVIVE is a multi-million dollar micro-enterprise development facility set up to improve livelihood outcomes for 250,000 individuals and micro-entrepreneurs by giving them financial support through multiple financial instruments as well as technical assistance, and is in collaboration with multiple NGOs and supported by USAID, Michael & Susan Dell Foundation, Omidyar Network India, the British High Commission, and UNDP to name a few. We will overlay the vaccine distribution program with REVIVE communities to quickly and effectively distribute vaccines.
For $12 per person, we have a clear opportunity to make a difference as we are engaging with an expansive NGO network, municipal and state governments, hospitals, and healthcare workers to implement:
With the arrival of vaccines, India now has a real fighting chance against coronavirus.
Donate now to stop the spread of COVID-19 and the horrifying death toll in India.
GIF is a 501(c)3 non-profit organization focused on giving people around the world the opportunity to save lives and make a real difference. GIF inspires global philanthropy and changes the way people give by providing secure and transparent giving options to both individual and corporate donors. GIF showcases the work of credible non-profit organizations in India and empowers donors to choose which organizations to support – it is simple, smart, and powerful. Contributions are tax-deductible and within limits established by the law.
GIF is an all volunteer 501(c)3 organization that supports credible programs and organizations in India. GIF will not take any administrative fee for all funds raised. 100% of the funds raised will go directly to on-the-ground programs in support of the COVID-19 disaster in India.
No. GIF is not affiliated with any religious institutions.
GIF decided to use the gofundme platform as it provides an easy and efficient method for payments, while also providing multiple ways to amplify our campaign in a short period of time which is paramount to the immediate crisis in India.
U.S. donors will be provided with a tax receipt.
U.S. donors will receive a summary of how their funds were used and its impact.
You can still donate to GIF since this program will make a meaningful difference in the fight against COVID. And as a US-donor, you can also donate to India-based fundraising campaigns on Give India, Milaap, Ketto, and DonateKart. However, you will not receive a tax exemption for these donations.
Please email Dr. Amita Vyas for any specific questions.
India is implementing the world’s largest vaccination program. According to the latest government guidelines, all adults (ages 18+) are eligible to get vaccinated. The Central Government will continue providing free vaccinations for essential and priority populations (i.e., healthcare workers (HCWs), frontline workers (FLWs), and people above 45 years). Additionally, vaccine manufacturers can release 50% of the vaccine stocks directly to Indian states and in the open market. Many states have also announced free vaccines for all people above ages 18 years.
Beneficiaries will be vaccinated through three delivery models:
For each of the above models, we are partnering with an expert NGO or service provider. Here is a short list of selected, vetted, and credible implementation partners (to be confirmed soon):
Additionally, we are mapping NGOs in our pan-India network who can spread awareness, mobilize communities in different locations, and work with the expert organization(s) above to complete the vaccination process for beneficiary communities.
Since the onset of the pandemic, Samhita/CGF has engaged multiple stakeholders from private, public, philanthropic, and social sectors to facilitate priority healthcare and economic revival needs for diverse individuals, community groups, and micro/nano enterprises.
In the second wave, some of the groups that Samhita/CGF and its partners have been supporting since 2020 need urgent vaccination to revive their lives and livelihoods – farmers, street vendors, women self-help groups, differently abled traders, small retailers, carpenters, construction workers, sanitation workers, blue collar factory workers, etc.
Samhita/CGF understands that collaboration will drive accelerated efforts towards breaking the coronavirus chain with an urgent and mass vaccination drive. In India, there are multiple challenges and variables that could prove a barrier to the rapid vaccination that is required. Some of them include shortage of vaccines, vaccine hesitancy, timely delivery of vaccines, etc. While vaccine availability is not in complete control of entities like us, Samhita/CGF is focused on working with our partners to address vaccine access, vaccine hesitancy, vaccination registration process, and timely implementation.
Currently, our partners are working with the Central/State government vaccination centers and procuring vaccines directly from them. All partners are also in active communication with manufacturers, however, there are no confirmations on supply from there.
The program will have the addition of mask distribution and nutrition packages to accompany vaccinations. We have partners who are actively working on vaccine awareness and sensitization among communities, supporting citizens through the vaccine registration process, and providing access to health and social security schemes of the government.
Mobilization under our programs is carried out through partners that have close connections with the community:
Yes, our partners in a few states are actively working with local/state governments to access vaccines, vaccinators, and local infrastructure.
On one particular day, 100-150 people can be vaccinated through our vaccination program.
Samhita/CGF is actively working in Maharashtra on a program to vaccinate 37,000 citizens below the poverty line in the next five months.
No, organizations and/or citizens cannot choose the vaccines if they are procured from the Central or state government model. Alternatively, programs involving direct procurement from manufacturers could be explored.
Recently, there were news reports on vaccine shortages in the media. The shortage had also led to a pause in vaccine drives in certain states and specific geographies. Through multiple anecdotal communications and news reports, it is expected that this shortage will be resolved by the Government of India (GoI) and state government to some extent by mid-May and early June. However, there is still a lack of clarity on the availability of vaccines to the private sector. The proportion of vaccines that may be made available by the two vaccine manufacturers for private consumption would be less initially as per the CEOs of these organizations.
Our potential implementation partners will be undertaking programs on vaccine availability in government/private centers they are partnered with or on their ability to procure from the open market at negotiated prices.
As per the latest announcements, Covishield will be made available to the Central and state Government at INR 300 per dose (INR 150 per dose for Central Government was for the initial contract for starting the vaccination production) and private players at INR 600 per dose.
Covaxin procurement prices for Central and state Governments are INR 400 per dose and for private players INR 1,200 per dose. The situation on pricing strategy is evolving rapidly and is subject to change depending on the revised government guidelines or price changes by the manufacturers.
Furthermore, a few states have announced their free vaccination programs for specific age groups and communities. Such announcements are dynamic and evolving on a day-to-day basis. At the present, 24 states have announced free vaccines for all eligible age groups (ages 18+):
Bihar, Jharkhand, Uttar Pradesh, Punjab, Haryana, Madhya Pradesh, Chhattisgarh, Sikkim, West Bengal, Assam, Goa, Tamil Nadu, Telangana, Andhra Pradesh, Kerala, Odisha, Tamil Nadu, Delhi, Jammu and Kashmir, Himachal Pradesh, Gujarat, Rajasthan, Jharkhand, Karnataka, Maharashtra.